Xolair Sales Data
| Rank 82 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Xolair U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 82 ( 1) |
$207,891 | 1.91% | 293 | -1.68% |
| Q3 2013 | 83 ( 5) |
$204,001 | 0.07% | 298 | n/a |
| Q2 2013 | 78 (15) |
$203,853 | 11.87% | 298 | 7.97% |
| Q1 2013 | 93 (2) |
$182,221 | -0.33% | 276 | -0.72% |
| Q4 2012 | 91 | $182,829 | -0.81% | 278 | -4.79% |
| Q3 2012 | 91 ( ) |
$184,317 | n/a | 292 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
